COVID-19 Testing & Surveillance for Large Populations
Color enables fast, accurate, COVID-19 testing and surveillance for large populations, with a high-capacity, CLIA-certified lab, an integrated infrastructure, and full program logistics.Contact Us
Read the latest on Color’s COVID-19 response in the media here ›
Reduce Transmission with Our Integrated COVID-19 Testing Programs
Build flexible community testing programs at scale with fast, accurate testing and public health reporting.
Deploy high frequency COVID-19 testing and population surveillance to mitigate outbreaks on campus.
Mitigate risk and minimize outbreaks with large-scale, flexible testing and distributed workforce surveillance.
Looking to get tested at one of our Community Test Sites in California?
Color’s infrastructure is designed for large-scale, distributed population testing and surveillance to identify outbreaks quickly. We operate a CLIA-certified, high-capacity lab, processing thousands of tests daily, averaging a 24-hour turnaround.1
Color’s testing and surveillance infrastructure is flexible, with access to real-time population health data for fast response to changing environments. We support clinician-monitored and self-collected samples that can be done at home or onsite, reducing costs and increasing scalability.
Experience & Expertise
Color works with hundreds of companies and large public entities including the City of San Francisco, processing close to 300,000 COVID-19 tests since April with over 70% of results returned in less than 24 hours and over 90% in less than 48 hours.1 We provide organizations with an integrated program including program management, logistics, best practices and effective communication strategies.
Monitored & Self Collection Testing
Color operates under FDA Emergency Use Authorizations (EUA) to offer both clinician-monitored and self-collected samples that can be done at home or onsite. By eliminating the need for clinicians to collect samples, Color lowers the cost and increases scalability of frequent testing for large populations.
Our cost-effective, accessible test kits are ideal for supporting mass-scale testing at universities, public health test sites and workplaces.
Color works with the scientific community to provide effective testing protocols. See our outbreak modeling tool >
Color was the first lab in the U.S. with FDA EUA approval for RT-LAMP technology, a COVID-19 testing method that is as accurate as RT-PCR, about 50% faster, and relies on less constrained supply chains. Our high-throughput, CLIA-certified lab is fully automated to drive down costs and make testing simple and accessible. Read more on our Lab and Assay.
Color’s COVID-19 Testing FAQs
Color uses nucleic acid amplification techniques (RT-LAMP and RT-PCR) to detect the presence of SARS-CoV-2 viral RNA. Learn more about our testing and assay.
Color accepts both nasal and throat swabs. The vast majority of our testing uses anterior nares (AN) swabs, a non-invasive swab that collects specimens from the front part of both nostrils. Our unmonitored kits use dry AN swabs. Nasopharyngeal (NP) swabs must be administered by a clinician.
Getting tested takes about 10–15 minutes. Results typically take 24-72 hours, and in practice our average turnaround is 24 hours1 , though the actual time may vary. Turnaround time is the usual number of hours from the time a specimen is accessioned at the laboratory to when the result is released to the participant and ordering provider.
Depending on the type of program you have, Color will provide a unique URL or program code that allows participants to enroll in testing. They’ll be asked for basic information such as phone number and email address, and required CDC health information.
Color recently received an EUA from the FDA for self-swab sample collection. Each kit comes with detailed instructions on how to activate the kit, collect a sample, and repackage the kit. Our kits use AN swabs and are physician ordered. Processes for kit pick-up and dropoff will depend on the type of program you have.
First, participants confirm some basic information to check-in at the Color testing site. Then they proceed to sample collection where they provide consent for the test, and provide the sample via nasal swab. They’ll also receive a handout with a sample-specific barcode for results release.
When test results become available, participants receive a text message and/or email notification that links them to a HIPAA-compliant portal to view their results.
For university, employer, and public entity programs, we provide administrative teams with a program dashboard to effectively monitor participant health. The participant and ordering physician receive results directly through Color’s participant and provider portals. Participants provide consent for testing and HIPAA authorization for results sharing as part of our scheduling system before being tested.
Color has created a framework to contain the spread of COVID-19 in the workplace, which can be found in our Return to On-Site Screening Strategies white paper.
As a clinical testing provider, Color adheres to the strictest privacy and security controls. Color is HIPAA-compliant and has worked with institutions ranging from the NIH to Fortune 500 employers. You may view our COVID terms of service, Notice of Privacy Practices, COVID HIPAA authorization, and COVID informed consent to learn more.
To get tested at one of our community sites, click here.
To learn more about our community testing programs, fill out this form and a member of our team will get back to you..